
Acadia Healthcare (ACHC) Stock Forecast & Price Target
Acadia Healthcare (ACHC) Analyst Ratings
Bulls say
Acadia Healthcare Co Inc shows a robust outlook due to strong demand in the behavioral health sector, which has resulted in impressive organic growth through bed expansions and strategic de novo development. The company's operational improvements at underperforming facilities, alongside projected increases in state-directed Medicaid payments, suggest potential for enhanced earnings and overall financial performance. Additionally, Acadia's long-term growth targets indicate expectations of 7-9% revenue growth and 8-10% EBITDA growth from 2024 to 2028, further reinforcing a positive financial trajectory.
Bears say
Acadia Healthcare Co Inc is experiencing a significant negative outlook primarily due to persistent volume softness, leading to a projected FY25 EBITDA that could fall 10% below current estimates, along with a contraction in the enterprise multiple to 6.0x. The company's long-term targets indicate a decrease in the EBITDA margin from 22.5% in 2024 to 21.7% by 2028, raising concerns about its profitability trajectory. Recent guidance was disappointing, with a weaker-than-expected forecast for 2025 and a revised multi-year outlook that reflects a concerning reset in intermediate-term margin expectations, contributing to a 25% decline in stock value.
This aggregate rating is based on analysts' research of Acadia Healthcare and is not a guaranteed prediction by Public.com or investment advice.
Acadia Healthcare (ACHC) Analyst Forecast & Price Prediction
Start investing in Acadia Healthcare (ACHC)
Order type
Buy in
Order amount
Est. shares
0 shares